ISSN 2398-2942      

Canine parvovirus


Synonym(s): Parvo




  • Family: Parvoviridae.
  • Genus: Parvovirus.
  • CPV 1: also known as minute virus of canines.
  • CPV 2: several variants identified including CPV 2a, 2b and 2c.


  • Latin: parvus- small.

Active Forms

This article is available in full to registered subscribers

Sign up now to start a free trial to access all Vetlexicon articles, images, sounds and videos, or Login

Clinical Effects



  • Canine parvovirus survives in the gastrointestinal tract of dogs.
  • Cats may be a potential reservoir, as canine and feline parvoviruses are closely related.
  • CPV 2a and CPV 2b can infect cats.
  • May survive for years in the environment.


  • Replicates in actively dividing cells of the natural host.
  • Single-stranded DNA virus.
  • Virions are assembled in the cell nucleus, associated with the formation of intranuclear inclusion bodies.


  • Feco-oral route.
  • Environmental contamination more important than contact with infected dog.
  • Via food and water contaminated with feces containing virus. The virus can survive in the environment for long periods.

Pathological effects

  • Virus targets lymphoid tissue, resulting in (in the early stages at least) lymphocytolysis and leukopenia.
  • Viremia followed by infection of bone marrow → leukopenia.


  • Mild diarrhea.


  • Initial sites of replication are lymph nodes and spleen.
  • Viremia occurs 2-5 days after infection.
  • The intestinal mucosa is involved after 6 days, targets intestinal crypt cells → complete denudation of mucosa in severe infections → fecal excretion follows.
  • Damage to the small intestine allows secondary bacterial infection, vomiting, diarrhea, and endotoxemia (diarrhea often hemorrhagic).
  • As parvovirus can cross the placenta pregnant bitches should not be immunized with modified live parvovirus vaccine; could cause abortion or fetal infection.
  • Myocarditis may occur in puppies when infected between 3 and 8 weeks old. Necrosis and infiltration by mononuclear cells occurs in the ventricular myocardium.

Other Host Effects

  • Virus is excreted in the feces for up to 8 weeks after recovery. This maintains the virus in the environment.


Control via chemotherapies

  • Interferon Interferon.
  • Symptomatic:
    • Replace fluid and electrolyte losses.
    • May use antibiotics to prevent 2° sepsis.
    • Anti-emetics to control vomiting.


  • Most adult animals are immune due to vaccination or exposure.
  • Antibody levels correlate directly with degree of protection.
  • Modified live vaccine usually stimulates a good antibody response.
  • Live modified vaccine available Therapeutics: immunological preparation Vaccination protocols.
  • Interference from maternal immunity is a significant problem. Initial puppy vaccinations are recommended to finish at an age when maternally derived antibody has declined to low levels such that the animal can respond to vaccination: this may be up to 16 weeks especially where prevalence of infection in the population is high.

Other countermeasures

  • Prompt cleaning with effective disinfectants, eg bleach.
  • Remove organic material, eg feces prior to disinfection.


This article is available in full to registered subscribers

Sign up now to start a free trial to access all Vetlexicon articles, images, sounds and videos, or Login

Further Reading


Refereed papers

  • Recent references from PubMed and VetMedResource.
  • Decaro N, Martella V, Elia G et al (2007) Tissue distribution of the antigenic variants of canine parvovirus type 2 in dogs. Vet Microbiol 121 (1-2), 39-44 PubMed.
  • Martella V, Decaro N & Buonavoglia (2006) Evolution of CPV-2 and impliance for antigenic/genetic characterisation. Virus Genes 33 (1), 11-13 PubMed.
  • Martella C, Cavalli A, Pratelli A et al (2004) A canine parvovirus mutant is spreading in Italy. J Clin Microbiol 42 (3), 1333-1336 PubMed.
  • Cohn L A, Rewerts J M, McCaw D et al (1999) Plasma granulocyte colony-stimulating factor concentrations in neutropenic, parvoviral enteritis-infected puppies. JVIM 13 (6), 581-586 PubMed.
  • Horiuchi M, Yamaguchi Y, Gojobori T et al (1998) Differences in the evolutionary pattern of feline panleukopenia virus and canine parvovirus. Virology 249 (2), 440-452 PubMed.
  • Houston D M, Ribble C S & Head L L (1996) Risk factors associated with parvovirus enteritis in dogs: 283 cases. JAVMA 208 (4), 542-546 PubMed.
  • Greenwood N M, Chalmers W S, Baxendale W et al (1995) Comparison of isolates of canine parvovirus by restriction enzyme analysis, and vaccine efficacy against field strains. Vet Rec 136 (3), 63-67 PubMed.

Can’t find what you’re looking for?

We have an ever growing content library on Vetlexicon so if you ever find we haven't covered something that you need please fill in the form below and let us know!


To show you are not a Bot please can you enter the number showing adjacent to this field